GeneDx Holdings Corp. (WGS)

GeneDx Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	60.32	105	85.21	99.68	123.93	400.57
Short-Term Investments	72.23	66.29	55.97	30.47	-	-
Cash & Short-Term Investments	132.55	171.28	141.19	130.15	123.93	400.57
Cash Growth	-1.49%	21.32%	8.48%	5.01%	-69.06%	270.44%
Accounts Receivable	83.61	74.37	37.63	32.82	43.34	26.56
Other Receivables	-	-	-	-	1.3	-
Receivables	83.61	74.37	37.63	32.82	44.64	26.56
Inventory	17.82	13.95	10.65	8.78	13.67	33.46
Prepaid Expenses	11.35	7.17	7.43	8.64	16.61	19.15
Restricted Cash	-	-	-	-	13.47	-
Other Current Assets	1.04	1.51	1.08	1.96	0.3	3.8
Total Current Assets	246.36	268.29	197.97	182.34	212.62	483.54
Property, Plant & Equipment	87.85	69.11	58.51	59.38	84.29	62.72
Goodwill	1.64	13.52	-	-	-	-
Other Intangible Assets	141.35	168.48	158.6	172.63	186.65	-
Other Long-Term Assets	4.28	4.32	4.31	4.41	7.39	7.83
Total Assets	481.49	523.71	419.38	418.76	490.94	554.09

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.15	2.46	7.95	10.24	46.02	44.69
Accrued Expenses	47.48	75.71	30.1	27.88	44.2	47.19
Current Portion of Long-Term Debt	-	4.54	1.21	-	4.75	-
Current Portion of Leases	5.71	4.4	3.34	3.65	6.12	-
Current Unearned Revenue	-	-	-	-	-	0.47
Other Current Liabilities	16.29	21.79	12.22	17.06	43.21	8.93
Total Current Liabilities	74.63	108.91	54.82	58.82	144.3	101.28
Long-Term Debt	96.84	48.18	51.91	52.69	6.25	11
Long-Term Leases	64.86	56.05	60.92	62.94	60.01	-
Long-Term Deferred Tax Liabilities	0.87	0.76	0.97	1.56	2.66	-
Other Long-Term Liabilities	0.07	1.64	5.52	14.74	24.02	53.71
Total Liabilities	237.27	215.53	174.13	190.74	237.24	165.99

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0.02
Additional Paid-In Capital	1,698	1,681	1,597	1,528	1,378	963.52
Retained Earnings	-1,455	-1,373	-1,352	-1,300	-1,124	-575.44
Comprehensive Income & Other	0.34	0.94	0.83	0.43	-	-
Total Common Equity	244.22	308.18	245.25	228.02	253.71	388.1
Shareholders' Equity	244.22	308.18	245.25	228.02	253.71	388.1
Total Liabilities & Equity	481.49	523.71	419.38	418.76	490.94	554.09

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	167.4	113.17	117.38	119.27	77.13	11
Net Cash (Debt)	-34.85	58.11	23.81	10.88	46.8	389.57
Net Cash Growth	-	144.11%	118.91%	-76.76%	-87.99%	517.31%
Net Cash Per Share	-1.19	2.03	0.89	0.45	4.57	118.95
Filing Date Shares Outstanding	29.82	29.29	28.07	26.05	24.19	7.42
Total Common Shares Outstanding	29.8	29.25	28.02	25.98	11.77	7.35
Working Capital	171.73	159.38	143.15	123.52	68.33	382.26
Book Value Per Share	8.19	10.54	8.75	8.78	21.55	52.78
Tangible Book Value	101.23	126.18	86.65	55.39	67.06	388.1
Tangible Book Value Per Share	3.40	4.31	3.09	2.13	5.70	52.78
Machinery	54.06	43.74	25.76	21.91	54.21	38.43
Construction In Progress	11.67	7.45	4.96	3.11	3.39	0.94
Leasehold Improvements	14.82	14.8	14.66	14.61	35.56	21.91

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error